Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Houlihan Lokey is a capital markets business based in the US. Houlihan Lokey shares (HLI) are listed on the NYSE and all prices are listed in US Dollars. Houlihan Lokey employs 2,257 staff and has a trailing 12-month revenue of around $2.3 billion.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $99.07 |
|---|---|
| 52-week range | $73.33 - $112.64 |
| 50-day moving average | $94.39 |
| 200-day moving average | $85.74 |
| Wall St. target price | $93.17 |
| PE ratio | 17.8262 |
| Dividend yield | $1.92 (2.17%) |
| Earnings per share (TTM) | $5.41 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $99.07 from 2023-01-31
| 1 week (2023-01-26) | 2.19% |
|---|---|
| 1 month (2022-12-29) | 11.70% |
| 3 months (2022-11-01) | 8.84% |
| 6 months (2022-08-02) | 18.12% |
| 1 year (2022-02-02) | -4.21% |
|---|---|
| 2 years (2021-02-02) | 48.87% |
| 3 years (2020-01-31) | 91.07% |
| 5 years (2018-02-02) | 109.27% |
Valuing Houlihan Lokey stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Houlihan Lokey's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Houlihan Lokey's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Houlihan Lokey shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Houlihan Lokey's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.54. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Houlihan Lokey's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $2.3 billion |
|---|---|
| Operating margin TTM | 22.87% |
| Gross profit TTM | $2.2 billion |
| Return on assets TTM | 15.25% |
| Return on equity TTM | 25.72% |
| Profit margin | 16.33% |
| Book value | $21.07 |
| Market capitalisation | $6.6 billion |
TTM: trailing 12 months
Dividend payout ratio: 42.71% of net profits
Recently Houlihan Lokey has paid out, on average, around 42.71% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.17% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Houlihan Lokey shareholders could enjoy a 2.17% return on their shares, in the form of dividend payments. In Houlihan Lokey's case, that would currently equate to about $1.92 per share.
While Houlihan Lokey's payout ratio might seem fairly standard, it's worth remembering that Houlihan Lokey may be investing much of the rest of its net profits in future growth.
Houlihan Lokey's most recent dividend payout was on 14 December 2022. The latest dividend was paid out to all shareholders who bought their shares by 30 November 2022 (the "ex-dividend date").
Over the last 12 months, Houlihan Lokey's shares have ranged in value from as little as $73.3315 up to $112.6407. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Houlihan Lokey's is 0.7701. This would suggest that Houlihan Lokey's shares are less volatile than average (for this exchange).
Houlihan Lokey, Inc. , an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
